Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European …

SE Inzucchi, RM Bergenstal, JB Buse… - Diabetes …, 2012 - Am Diabetes Assoc
Moderate aLimited use in the US/Europe. bNot licensed in the US cPrescribing highly
restricted in the US; withdrawn in Europe. dNot licensed in Europe. eTo be available as a …

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the …

SE Inzucchi, RM Bergenstal, JB Buse… - Diabetes …, 2015 - Am Diabetes Assoc
In 2012, the American Diabetes Association (ADA) and the European Association for the
Study of Diabetes (EASD) published a position statement on the management of …

Diabetes and cancer: a consensus report

E Giovannucci, DM Harlan, MC Archer… - CA: a cancer journal …, 2010 - Wiley Online Library
Epidemiologic evidence suggests that cancer incidence is associated with diabetes as well
as certain diabetes risk factors and treatments. This consensus statement of experts …

[HTML][HTML] Liraglutide and cardiovascular outcomes in type 2 diabetes

SP Marso, GH Daniels… - … England Journal of …, 2016 - Mass Medical Soc
Background The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue,
when added to standard care in patients with type 2 diabetes, remains unknown. Methods In …

Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range

T Battelino, T Danne, RM Bergenstal, SA Amiel… - Diabetes …, 2019 - Am Diabetes Assoc
Improvements in sensor accuracy, greater convenience and ease of use, and expanding
reimbursement have led to growing adoption of continuous glucose monitoring (CGM) …

[HTML][HTML] Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the …

SE Inzucchi, RM Bergenstal, JB Buse, M Diamant… - Diabetologia, 2012 - Springer
Glycaemic management in type 2 diabetes mellitus has become increasingly complex and,
to some extent, controversial, with a widening array of pharmacological agents now …

International consensus on use of continuous glucose monitoring

T Danne, R Nimri, T Battelino, RM Bergenstal… - Diabetes …, 2017 - Am Diabetes Assoc
Measurement of glycated hemoglobin (HbA1c) has been the traditional method for
assessing glycemic control. However, it does not reflect intra-and interday glycemic …

[HTML][HTML] Alogliptin after acute coronary syndrome in patients with type 2 diabetes

WB White, CP Cannon, SR Heller… - New England journal …, 2013 - Mass Medical Soc
Background To assess potentially elevated cardiovascular risk related to new
antihyperglycemic drugs in patients with type 2 diabetes, regulatory agencies require a …

Current state of type 1 diabetes treatment in the US: updated data from the T1D Exchange clinic registry

KM Miller, NC Foster, RW Beck, RM Bergenstal… - Diabetes …, 2015 - Am Diabetes Assoc
To examine the overall state of metabolic control and current use of advanced diabetes
technologies in the US, we report recent data collected on individuals with type 1 diabetes …

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

DE Bonds, ME Miller, RM Bergenstal, JB Buse… - Bmj, 2010 - bmj.com
Objective To determine whether there is a link between hypoglycaemia and mortality among
participants in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Design …